Lv7
4500 积分 2022-07-22 加入
TQB3617, a bromodomain and extra-terminal inhibitor, in patients with relapsed or refractory lymphoma: A multicenter, phase 1 trial
3天前
已完结
Risk-adaptive Therapy Guided by Dynamic ctDNA in Nasopharyngeal Carcinoma
5天前
已完结
Dynamics of circulating tumour DNA can guide treatment decisions for improved outcomes
6天前
已完结
Clinical development of cancer vaccines
6天前
已完结
Resistance to the KRASG12D Inhibitor MRTX1133 is Associated with Increased Sensitivity to BET Inhibition
7天前
已完结
Comprehensive Multi-Omic Characterization of Perineural Invasion in Cervical Cancer Reveals Diagnostic Markers, Molecular Drivers, and Therapeutic Strategies
7天前
已完结
Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC program
8天前
已完结
BET inhibitor OPN-2853 in advanced solid tumors and lymphoma: results from the phase 1b PLX124-01 trial
11天前
已完结
Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer
12天前
已完结
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
15天前
已完结
皖公网安备34019202002308
